CARA earnings call for the period ending June 30, 2020.
News & Analysis: Cara Therapeutics
Both of these biotechs could have big catalysts on the way.
These companies are all surprising doubters lately.
CARA earnings call for the period ending March 31, 2020.
Which stock wins in a battle between these two clinical-stage biotechs?
The company plans to submit its pruritis drug for FDA and EMA approval later this year.
CARA earnings call for the period ending December 31, 2019.
These stocks went in opposite directions in 2019. Will that trend continue this year?
These pharma stocks have gone in different directions in the last year, but both hold promise for forward-thinking investors.
Despite their differences, there's a lot of good things going on for both of these health companies.